BMRA - BIOMERICA INC
1.92
-0.050 -2.604%
Share volume: 18,674
Last Updated: 03-06-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$1.97
-0.05
-0.03%
View ratios
| Fiscal Date | 11-30-2023 | 02-29-2024 | 05-31-2024 | 08-31-2024 | 11-30-2024 | 02-28-2025 | 08-31-2025 | 11-30-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 01-16-2024 | 04-12-2024 | 01-14-2025 | 10-15-2024 | 01-14-2025 | 04-14-2025 | 10-14-2025 | 01-14-2026 | |
| Assets | |||||||||
| Total Assets | 11.831 M | 10.342 M | 9.254 M | 7.870 M | 7.274 M | 7.376 M | 6.854 M | 6.034 M | |
| Current Assets | 10.265 M | 8.846 M | 7.731 M | 6.445 M | 5.945 M | 6.204 M | 5.899 M | 5.191 M | |
| Inventories | 1.841 M | 2.129 M | 2.376 M | 1.942 M | 1.789 M | 1.655 M | 1.473 M | 1.524 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 7.134 M | 5.319 M | 4.170 M | 2.820 M | 2.372 M | 3.058 M | 3.053 M | 2.543 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 210.000 K | 194.000 K | 201.000 K | 184.000 K | 167.000 K | 151.000 K | 120.000 K | 105.000 K | |
| Other Assets | 1.356 M | 1.302 M | 1.322 M | 1.241 M | 1.162 M | 1.021 M | 835.000 K | 738.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 11.831 M | 10.342 M | 9.254 M | 7.870 M | 7.274 M | 7.376 M | 6.854 M | 6.034 M | |
| Total liabilities | 2.448 M | 2.534 M | 2.663 M | 2.524 M | 2.160 M | 1.842 M | 1.699 M | 1.599 M | |
| Total current liabilities | 1.822 M | 1.991 M | 2.204 M | 2.151 M | 1.876 M | 1.649 M | 1.693 M | 1.599 M | |
| Accounts Payable | 783.000 K | 885.000 K | 1.138 M | 1.089 M | 848.000 K | 632.000 K | 681.000 K | 740.000 K | |
| Other liabilities | 626.000 K | 0.000 | 459.000 K | 373.000 K | 284.000 K | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 626.000 K | 0.000 | 459.000 K | 373.000 K | 284.000 K | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 9.383 M | 7.808 M | 6.591 M | 5.346 M | 5.114 M | 5.534 M | 5.155 M | 4.435 M | |
| Common stock | 54.343 M | 54.684 M | 54.888 M | 54.965 M | 55.687 M | 57.271 M | 58.423 M | 59.024 M | |
| Retained earnings | -44.856 M | -46.774 M | -48.195 M | -49.511 M | -50.461 M | -51.624 M | -53.166 M | -54.486 M |